NasdaqGS:HCAT

Stock Analysis Report

Executive Summary

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations.

Snowflake

Fundamentals

Reasonable growth potential with mediocre balance sheet.

Risks

  • Health Catalyst has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has Health Catalyst's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.2%

HCAT

0.9%

US Healthcare Services

-0.2%

US Market


1 Year Return

n/a

HCAT

8.7%

US Healthcare Services

1.1%

US Market

No trading data on HCAT.

No trading data on HCAT.


Share holder returns

HCATIndustryMarket
7 Day3.2%0.9%-0.2%
30 Day-16.5%-5.2%2.5%
90 Dayn/a-5.5%1.6%
1 Yearn/a8.8%8.7%3.4%1.1%
3 Yearn/a49.7%49.4%45.2%35.8%
5 Yearn/a50.3%49.4%62.6%44.8%

Price Volatility Vs. Market

How volatile is Health Catalyst's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Health Catalyst undervalued based on future cash flows and its price relative to the stock market?


Intrinsic Value Based on Future Cash Flows

Health Catalyst's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Health Catalyst's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Health Catalyst is loss making, we can't compare its value to the US Healthcare Services industry average.

Health Catalyst is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Health Catalyst, we can't assess if its growth is good value.


Price Based on Value of Assets

Health Catalyst has negative assets, we can't compare the value of its assets to the US Healthcare Services industry average.


Next Steps

Future Growth

How is Health Catalyst expected to perform in the next 1 to 3 years based on estimates from 7 analysts?

36.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Health Catalyst's revenue is expected to grow by 19.4% yearly, however this is not considered high growth (20% yearly).

Health Catalyst's earnings are expected to grow significantly at over 20% yearly.

Health Catalyst's revenue growth is expected to exceed the United States of America market average.

Health Catalyst's earnings growth is expected to exceed the United States of America market average.

Health Catalyst's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Health Catalyst will efficiently use shareholders’ funds in the future (Return on Equity greater than 20%) as it is not expected to be profitable.


Next Steps

Past Performance

How has Health Catalyst performed over the past 5 years?

-227.4%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Health Catalyst does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.

Unable to compare Health Catalyst's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Health Catalyst's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Health Catalyst has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Health Catalyst has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Health Catalyst improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Health Catalyst's financial position?


Financial Position Analysis

Health Catalyst is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Health Catalyst's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Health Catalyst's level of debt (173.7%) compared to net worth is high (greater than 40%).

Unable to establish if Health Catalyst's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 2x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Health Catalyst has sufficient cash runway for 1.5 years based on current free cash flow.

Unable to confirm if Health Catalyst has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is Health Catalyst's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Health Catalyst's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Health Catalyst's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Health Catalyst has not reported any payouts.

Unable to verify if Health Catalyst's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Health Catalyst has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Health Catalyst's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

Dan Burton (44yo)

6.9yrs

Tenure

US$4,572,740

Compensation

Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has many years of strate ...


CEO Compensation Analysis

Dan's remuneration is about average for companies of similar size in United States of America.

Insufficient data for Dan to compare compensation growth.


Management Age and Tenure

2.0yrs

Average Tenure

53.5yo

Average Age

The tenure for the Health Catalyst management team is about average.


Board Age and Tenure

5.3yrs

Average Tenure

61yo

Average Age

The tenure for the Health Catalyst board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Dan Orenstein (49yo)

    General Counsel & Secretary

    • Tenure: 3.7yrs
  • J. Patrick Nelli

    Chief Financial Officer

    • Tenure: 2yrs
    • Compensation: US$1.70m
  • Steve Barlow

    Co-Founder & Senior VP (Leave of Absence)

    • Tenure: 11.7yrs
  • Tom Burton

    Co-Founder & President of Professional Services

    • Tenure: 11.7yrs
  • Paul Horstmeier (58yo)

    Chief Operating Officer

    • Tenure: 0.9yrs
  • Dan Burton (44yo)

    CEO & Director

    • Tenure: 6.9yrs
    • Compensation: US$4.57m
  • Dale Sanders (59yo)

    Chief Technology Officer

    • Tenure: 0.6yrs
    • Compensation: US$3.17m
  • Adam Brown

    Senior Vice President of Investor Relations

    • Tenure: 0yrs
  • Trudy Sullivan

    Chief Communications & Diversity & Inclusion Officer

    • Tenure: 0.3yrs
  • Jason Jones

    Chief Data Scientist

    • Tenure: 0.8yrs

Board Members

  • Promod Haque (71yo)

    Director

    • Tenure: 6.8yrs
  • Jack Kane (66yo)

    Director

    • Tenure: 4.7yrs
    • Compensation: US$50.00k
  • Todd Cozzens (63yo)

    Director

    • Tenure: 7yrs
    • Compensation: US$40.00k
  • D. Bullock (66yo)

    Director

    • Tenure: 5.3yrs
  • Mike Dixon (35yo)

    Director

    • Tenure: 8yrs
  • Anita Pramoda (44yo)

    Director

    • Tenure: 3.4yrs
    • Compensation: US$35.00k
  • Duncan Gallagher (59yo)

    Director

    • Tenure: 2.3yrs
    • Compensation: US$120.00k
  • Dan Burton (44yo)

    CEO & Director

    • Tenure: 6.9yrs
    • Compensation: US$4.57m
  • Fraser Bullock (63yo)

    Director

    • Tenure: 5.3yrs
  • Timothy Ferris (56yo)

    Director

    • Tenure: 1.7yrs
    • Compensation: US$389.97k

Company Information

Health Catalyst, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Health Catalyst, Inc.
  • Ticker: HCAT
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$1.331b
  • Shares outstanding: 36.49m
  • Website: https://www.healthcatalyst.com

Number of Employees


Location

  • Health Catalyst, Inc.
  • 3165 East Millrock Drive
  • Suite 400
  • Salt Lake City
  • Utah
  • 84121
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HCATNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJul 2019

Biography

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 01:28
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.